Observational Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Feb 27, 2023; 15(2): 234-248
Published online Feb 27, 2023. doi: 10.4240/wjgs.v15.i2.234
Table 4 Multivariate logistic regression analysis to predict no regression of hepatobiliary symptoms
OR (95%CI)2
P value
Steroid treatment3.68 (1.29-10.45)0.0151
High ALT5.39 (2.19-13.28)< 0.0011
High AST2.59 (1.08-6.20) 0.0321
High ALP73.59 (9.52-568.93)< 0.0011
High bilirubin2.72 (1.16-6.4)0.0221
Jaundice2.49 (1.07-5.8)0.0341
Pruritus9.75 (3.12-30.50)< 0.0011
Fever9.7 (1.25-75.03)0.0291
1Significant.
2Adjusted for age, gender, smoking, family history of UC, and UC duration; OR: Odds ratio; 95%CI: 95% confidence interval.
UC: Ulcerative colitis; ALT: Alanine aminotransferase; AST: Aspartate transaminase ALP: Alkaline phosphatase.
  • Citation: Habeeb TAAM, Hussain A, Podda M, Cianci P, Ramshaw B, Safwat K, Amr WM, Wasefy T, Fiad AA, Mansour MI, Moursi AM, Osman G, Qasem A, Fawzy M, Alsaad MIA, Kalmoush AE, Nassar MS, Mustafa FM, Badawy MHM, Hamdy A, Elbelkasi H, Mousa B, Metwalli AEM, Mawla WA, Elaidy MM, Baghdadi MA, Raafat A. Hepatobiliary manifestations following two-stages elective laparoscopic restorative proctocolectomy for patients with ulcerative colitis: A prospective observational study. World J Gastrointest Surg 2023; 15(2): 234-248
  • URL: https://www.wjgnet.com/1948-9366/full/v15/i2/234.htm
  • DOI: https://dx.doi.org/10.4240/wjgs.v15.i2.234